+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Mucosal Barrier Injury Laboratory-Confirmed Bloodstream Infections (MBI-LCBI): Descriptive Analysis of Data Reported to National Healthcare Safety Network (NHSN), 2013



Mucosal Barrier Injury Laboratory-Confirmed Bloodstream Infections (MBI-LCBI): Descriptive Analysis of Data Reported to National Healthcare Safety Network (NHSN), 2013



Infection Control and Hospital Epidemiology 37(1): 2-7



OBJECTIVES To determine the impact of mucosal barrier injury laboratory-confirmed bloodstream infections (MBI-LCBIs) on central-line-associated bloodstream infection (CLABSI) rates during the first year of MBI-LCBI reporting to the National Healthcare Safety Network (NHSN) DESIGN Descriptive analysis of 2013 NHSN data SETTING Selected inpatient locations in acute care hospitals METHODS A descriptive analysis of MBI-LCBI cases was performed. CLABSI rates per 1,000 central-line days were calculated with and without the inclusion of MBI-LCBIs in the subset of locations reporting ≥1 MBI-LCBI, and in all locations (regardless of MBI-LCBI reporting) to determine rate differences overall and by location type. RESULTS From 418 locations in 252 acute care hospitals reporting ≥1 MBI-LCBIs, 3,162 CLABSIs were reported; 1,415 (44.7%) met the MBI-LCBI definition. Among these locations, removing MBI-LCBI from the CLABSI rate determination produced the greatest CLABSI rate decreases in oncology (49%) and ward locations (45%). Among all locations reporting CLABSI data, including those reporting no MBI-LCBIs, removing MBI-LCBI reduced rates by 8%. Here, the greatest decrease was in oncology locations (38% decrease); decreases in other locations ranged from 1.2% to 4.2%. CONCLUSIONS An understanding of the potential impact of removing MBI-LCBIs from CLABSI data is needed to accurately interpret CLABSI trends over time and to inform changes to state and federal reporting programs. Whereas the MBI-LCBI definition may have a large impact on CLABSI rates in locations where patients with certain clinical conditions are cared for, the impact of MBI-LCBIs on overall CLABSI rates across inpatient locations appears to be more modest. Infect. Control Hosp. Epidemiol. 2015;37(1):2-7.

Please choose payment method:






(PDF emailed within 0-6 h: $19.90)

Accession: 058353881

Download citation: RISBibTeXText

PMID: 26456954

DOI: 10.1017/ice.2015.245


Related references

Impact of removing mucosal barrier injury laboratory-confirmed bloodstream infections from central line-associated bloodstream infection rates in the National Healthcare Safety Network, 2014. American Journal of Infection Control 45(3): 321-323, 2017

Mucosal barrier injury laboratory-confirmed bloodstream infection: results from a field test of a new National Healthcare Safety Network definition. Infection Control and Hospital Epidemiology 34(8): 769-776, 2013

Impact of mucosal barrier injury laboratory-confirmed bloodstream infection (MBI-LCBI) on central line-associated bloodstream infections (CLABSIs) in department of hematology at single university hospital in Japan. Journal of Infection and ChemoTherapy, 2017

Incidence and Outcome of Pediatric Hematopoietic Transplant Patients Diagnosed with the New Classification Mucosal Barrier Injury Laboratory-Confirmed Bloodstream Infections (MBI-LCBI). Biology of Blood and Marrow Transplantation 21(2): S216-S217, 2015

Healthcare Burden, Risk Factors, and Outcomes of Mucosal Barrier Injury Laboratory-Confirmed Bloodstream Infections after Stem Cell Transplantation. Biology of Blood and Marrow Transplantation 22(9): 1671-1677, 2016

NHSN annual update: antimicrobial-resistant pathogens associated with healthcare-associated infections: annual summary of data reported to the National Healthcare Safety Network at the Centers for Disease Control and Prevention, 2006-2007. Infection Control and Hospital Epidemiology 29(11): 996-1011, 2008

Central Line-Associated Bloodstream Infections and Mucosal Barrier Injury Laboratory-Confirmed Bloodstream Infections: Results from a Quality-Improvement Project in a Hematology-Oncology Unit. American Journal of Infection Control 46(6): S40-S41, 2018

Methicillin-resistant Staphylococcus aureus bloodstream infection surveillance: National Healthcare Safety Network's laboratory-identified event reporting versus traditional laboratory-confirmed bloodstream infection surveillance. Infection Control and Hospital Epidemiology 35(10): 1286-1289, 2014

Completeness of surveillance data reported by the National Healthcare Safety Network: an analysis of healthcare-associated infections ascertained in a tertiary care hospital, 2010. Infection Control and Hospital Epidemiology 33(1): 94-96, 2012

Mucosal barrier injury laboratory--confirmed bloodstream infection or contaminant?. Infection Control and Hospital Epidemiology 34(12): 1330-1331, 2013

National Healthcare Safety Network (NHSN) Report, data summary for 2010, device-associated module. American Journal of Infection Control 39(10): 798-816, 2011

National Healthcare Safety Network (NHSN) report, data summary for 2009, device-associated module. American Journal of Infection Control 39(5): 349-367, 2011

National Healthcare Safety Network (NHSN) report, data summary for 2012, Device-associated module. American Journal of Infection Control 41(12): 1148-1166, 2013

Dialysis Surveillance Report: National Healthcare Safety Network (NHSN)-data summary for 2006. Seminars in Dialysis 21(1): 24-28, 2008

Healthcare-associated infections studies project: an American Journal of Infection Control and National Healthcare Safety Network data quality collaboration-Ventilator-associated event 1, 2013. American Journal of Infection Control 41(11): 1085-1086, 2014